Orient Pharma Co., Ltd. (TPEX:4166)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.60
+0.25 (0.65%)
Feb 18, 2025, 9:00 AM CST
85.58%
Market Cap 8.49B
Revenue (ttm) 1.07B
Net Income (ttm) 119.10M
Shares Out 223.04M
EPS (ttm) 0.53
PE Ratio 71.26
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 108,349
Average Volume 123,550
Open 38.25
Previous Close 38.35
Day's Range 37.95 - 39.00
52-Week Range 19.45 - 50.70
Beta 0.09
RSI 54.89
Earnings Date Mar 17, 2025

About Orient Pharma

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and ... [Read more]

Sector Healthcare
Founded 2008
Employees 173
Stock Exchange Taipei Exchange
Ticker Symbol 4166
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.